Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients
Authors:
- Mojgan ShaieganMSMojgan Shaiegan
- Masoud IravaniMIMasoud Iravani
- Gholam Reza BabaeeGBGholam Reza Babaee
- Ardeshir GhavamzadehAGArdeshir Ghavamzadeh
- 1 January 2006
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 15 (3) , 223-227
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Role of interleukin-18 in acute graft-vs-host diseaseJournal of Laboratory and Clinical Medicine, 2003
- Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effectsBlood, 2003
- Interleukin-18Journal of Leukocyte Biology, 2003
- IL‐18‐independent cytotoxic T lymphocyte activation and IFN‐γ production during experimental acute graft‐versus‐host diseaseInternational Immunology, 2002
- Immunological reconstitution and immunoregulatory cells in hematopoietic stem cell transplantationInternational Journal of Hematology, 2002
- Interleukin-18 Binding Protein in Acute Graft versus Host Disease and Engraftment Following Allogeneic Peripheral Blood Stem Cell TransplantsJournal of Hematotherapy & Stem Cell Research, 2001
- Interleukin-18 Regulates Acute Graft-Versus-Host Disease by Enhancing Fas-mediated Donor T Cell ApoptosisJournal of Experimental Medicine, 2001
- Elevated interleukin (IL)‐18 levels during acute graft‐versus‐host disease after allogeneic bone marrow transplantationBritish Journal of Haematology, 2000
- Th2 and Tc2 Cells in the Regulation of GVHD, GVL, and Graft Rejection: Considerations for the Allogeneic Transplantation Therapy of Leukemia and LymphomaLeukemia & Lymphoma, 2000
- SERUM CYTOKINE LEVELS AFTER HLA-IDENTICAL BONE MARROW TRANSPLANTATION1Transplantation, 1998